AllCells’ Post

View organization page for AllCells, graphic

8,637 followers

5mo Edited

Thank you for attending today's LinkedIn Live. Unfortunately, we were unable to resolve the livestreaming issues and will continue to troubleshoot. Please stay tuned on our page for any updates. We will make a recording of the webinar available in the near future.

AllCells

8,637 followers

6mo

Join our panel of AllCells experts for a LinkedIn Live event to learn how our donor management approach achieves an average 98% collection deliverability for complex cell and gene therapy (CGT) projects. Gain practical insights from real-world case studies demonstrating how our unique approach can enable success for your programs. The webinar will be streamed on Thursday, April 10 at 3pm Eastern Time (ET). Register today: https://lnkd.in/gTRqecp2

To view or add a comment, sign in

More Relevant Posts

Jared Smith, Ph.D.

Principal Scientist in AAV Gene Therapy at REGENXBIO Inc., Head of CNS Research
1mo
Report this post
This is the #Hope of #genetherapy for #diseases of the #brain. One dose that provides lasting therapeutic benefit. #aav #MPS #drugdevelopment
REGENXBIO

32,919 followers
1mo

Today, we announced positive results from our pivotal CAMPSIITE® trial of RGX-121 for the treatment of MPS II, also known as Hunter syndrome, presented at the SSIEM 2024 Annual Symposium. With our upcoming BLA submission using the accelerated approval pathway, RGX-121 is on track to be the first potential first gene therapy and one-time treatment for MPS II, and the first treatment in the U.S. that addresses the neurocognitive decline associated with this disease. Learn more: https://lnkd.in/gZgtGsyB #SSIEM #SSIEM24
Like Comment
To view or add a comment, sign in
Cell and Gene Therapy Catapult

48,141 followers
9mo
Report this post
Are you looking to improve your understanding of the characteristics of a target product profile (TPP) and learn how to create a robust TPP to increase the likelihood of successful adoption of your #AdvancedTherapy? The Cell and Gene Therapy Catapult are hosting a webinar titled 'Developing a robust target product profile (TPP) for successful therapy adoption' on the 31st January where some of our key experts will be discussing our recently released TPP guide, the importance of a TPP and how to approach building one. Learn more: https://buff.ly/3RqT2nC #TargetProductProfile #CellTherapies #GeneTherapies #NonClinical
Like Comment
To view or add a comment, sign in
Yama Jan

Helping scientific community with their vital research through collaboration
1w
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/E21bDg #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in
Gianpiero Lazzari

PhD, Director - Business Development Gene Therapy CDMO services at Charles River
1w
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/zE5HWd #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in
Andria Riti

Sr. Manager, Communications and Branding at Charles River Laboratories
1w
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/hm75QJ #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in
Reno Franchetti

Associate Director, Regional Sales - Business Development | Gene Therapy Manufacturing
1w
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/zpnVjP #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in
Leon VanWormer, MBA

Business Development Manager, Gene Therapy CDMO Services - East @ Charles River Labs
1w Edited
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/8UhTGW #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in
Charles River Laboratories

192,918 followers
2mo
Report this post
Using a phase-appropriate approach, our recombinant off-the-shelf AAV and LVV viral vectors and plasmids make for more simplified gene therapy development. Empower breakthroughs in your discovery phase and start with the end in mind with a complete concept to cure portfolio through Charles River. Empower Your Research: https://okt.to/KTzQ5e
Like Comment
To view or add a comment, sign in
Jane Matthews

Process and Data-Driven Professional
1w
Report this post
How secure is your viral vector supply? A successful viral vector tech transfer at any stage of development requires expertise and precision, minimizing program impact and ensuring confidence around continuity of supply.  Register for the October 3 webinar hosted by Cell & Gene Therapy Insights and learn from MSAT subject matter experts to support your program: https://okt.to/cGDBjv #viralvectortechtransfer #viralvectors #cellandgenetherapy #genetherapy #msat Kevin Taylor James Cody
Like Comment
To view or add a comment, sign in

8,637 followers

View Profile Follow

AllCells’ Post

More from this author

Wrapping up the year, current discounts, and growth in 2023...

AllCells' acquisition, current promotions, events, and more...

What's new at AllCells? Q2 and beyond...

Explore topics